Karen L. Smith - Jul 2, 2024 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Jul 2, 2024
Transactions value $
$0
Form type
3
Date filed
7/5/2024, 08:58 AM
Previous filing
Jun 6, 2024
Next filing
Sep 5, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney